piur imaging secures 4.9 million euros in Series A financing

The Austrian medical technology company piur imaging has raised 4.9 million euros in a Series A financing round. With its AI-controlled tomographic 3D ultrasound solutions, the startup plans to provide healthcare at affordable prices.

Vienna - piur imaging has successfully closed a Series A financing round of 4.9 million euros. The round was led by Ascend Capital Partners, an EU Healthtech VC. Aescuvest, a healthcare investment firm from Munich, is also a new shareholder.

Ultrasound is one of the most important diagnostic imaging tools for vascular, thyroid, abdominal and cardiac diseases. It is cost-effective, has no side effects and is well suited for imaging soft tissue and blood vessels

Frederik Bender, Managing Director of piur imaging

With PIUR tUS Infinity, the start-up offers a manufacturer-independent tomographic 3D ultrasound solution on the market. The technology enables a conventional ultrasound system to be expanded to include a tomography function that allows volume images of organs and structures to be taken. Image acquisition and analysis are performed separately, enabling AI-based image analysis and asynchronous remote diagnosis. This makes ultrasound examinations less operator-dependent and more efficient.

piur will invest the fresh funding in research and development, marketing and sales as well as partnerships. The company is planning a major software update and the introduction of a second generation sensor to improve the usability and performance of the product. PIUR also plans to expand its team and grow its user base. Piur plans to expand into the US and expects to receive regulatory approval by the end of the year. The company is also planning a major collaboration with a leading pharmaceutical company and a leading ultrasound company in the coming months.

The product is meeting market demand. The company has also already built up a considerable customer base in the DACH region

Sebastian Gührs, Partner & Head of Investment Aescuvest.

Frederik Bender, Managing Director of piur imaging, emphasizes the importance of ultrasound as an important diagnostic imaging tool. However, the accuracy of the diagnosis depends on the skills and experience of the doctor. This is where piur comes in with its solution, which enables accurate volume measurements, in contrast to previous estimates.

Aescuvest, based in Munich, is an investment company that focuses on financing companies in the field of digital healthcare. Through its investment platform, the company offers exclusive access to promising healthcare companies and enables direct investments via SPV structures. Investors thus have the opportunity to take advantage of lucrative investment opportunities in the healthcare sector.